This is something that many should watch for in the following months. It could be a huge advantage for us or for some of us it may be a bust. It will depend on whether the American Association of Clinical Endocrinologist (AACE) follows their own recent guidelines allowing for individualized goals or if that will not be a part of this and individualized goals will be ignored for safety reasons.
We will need to watch for when this will happen on the AACE web site. The information that will be presented will be the AACE, cosponsoring the new online resource with Takeda Pharmaceuticals. The launch date is to be sometime in June. At present the emphasis seems to be for Type 2 diabetes. If this can fill the gap in education needed by people unaware of hypoglycemia mentioned in my last blog, then it will have succeeded quite well.
According to the spokesman, this will be a valuable resource for patients and health professionals as it will direct them to sources for new research and patient education. Whether the site will allow both sides to be seen by patients will remain to be seen.
The purpose of the new web site is to direct patients to educational resources that provide credible information about diabetes. It will not be there to provide a new patient information about diabetes, but assist them in avoiding unreliable information. It will be available for patients, caregivers, and healthcare professionals to aid all in forming a foundation for treatment and care decisions.
The sites they will be directed to will be vetted by AACE diabetes experts and the sites will be evaluated for quality and accuracy in the information it provides to patients and health professionals. The experts say that about 90 percent of people get their information from the internet and that on good days, 20 percent at most is reliable.
They also state that 90 to 95 percent of diabetics never see a specialist. So this is a resource of for thousands of physicians who provide healthcare to people with Type 2 diabetes. They want the online resource to help these healthcare professional to give them the most current guidelines for Type 2 diabetes treatment and methods for establishing individualized care plans for their patients with diabetes.
There is a lot to be done and it is going to be interesting to see the outcome of this effort. We do need this, if nothing more than a way to start eliminating many of the “cure” sites and sites that propagate much misinformation. It will also be interesting to see of the media picks up on this and does any research to improve their reporting.
Read the article here.
No comments:
Post a Comment